1. Home
  2. INVE vs MIST Comparison

INVE vs MIST Comparison

Compare INVE & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVE
  • MIST
  • Stock Information
  • Founded
  • INVE 1990
  • MIST 2003
  • Country
  • INVE United States
  • MIST Canada
  • Employees
  • INVE N/A
  • MIST N/A
  • Industry
  • INVE Computer peripheral equipment
  • MIST Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVE Technology
  • MIST Health Care
  • Exchange
  • INVE Nasdaq
  • MIST Nasdaq
  • Market Cap
  • INVE 86.5M
  • MIST 103.4M
  • IPO Year
  • INVE 1997
  • MIST N/A
  • Fundamental
  • Price
  • INVE $3.50
  • MIST $2.01
  • Analyst Decision
  • INVE Strong Buy
  • MIST Strong Buy
  • Analyst Count
  • INVE 2
  • MIST 3
  • Target Price
  • INVE $7.25
  • MIST $13.00
  • AVG Volume (30 Days)
  • INVE 41.3K
  • MIST 685.2K
  • Earning Date
  • INVE 03-11-2025
  • MIST 03-20-2025
  • Dividend Yield
  • INVE N/A
  • MIST N/A
  • EPS Growth
  • INVE N/A
  • MIST N/A
  • EPS
  • INVE 3.10
  • MIST N/A
  • Revenue
  • INVE $104,217,000.00
  • MIST N/A
  • Revenue This Year
  • INVE N/A
  • MIST N/A
  • Revenue Next Year
  • INVE N/A
  • MIST N/A
  • P/E Ratio
  • INVE $1.12
  • MIST N/A
  • Revenue Growth
  • INVE 70.57
  • MIST N/A
  • 52 Week Low
  • INVE $2.95
  • MIST $1.12
  • 52 Week High
  • INVE $9.24
  • MIST $2.75
  • Technical
  • Relative Strength Index (RSI)
  • INVE 39.83
  • MIST 54.31
  • Support Level
  • INVE $3.50
  • MIST $1.87
  • Resistance Level
  • INVE $3.82
  • MIST $2.13
  • Average True Range (ATR)
  • INVE 0.18
  • MIST 0.13
  • MACD
  • INVE -0.02
  • MIST -0.01
  • Stochastic Oscillator
  • INVE 12.73
  • MIST 50.00

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: